RadNet Receivables 2010-2024 | RDNT

RadNet receivables from 2010 to 2024. Receivables can be defined as the total amount of collectibles for a company
RadNet Annual Receivables
(Millions of US $)
2024 $186
2023 $164
2022 $166
2021 $135
2020 $130
2019 $155
2018 $149
2017 $156
2016 $164
2015 $163
2014 $148
2013 $134
2012 $129
2011 $128
2010 $96
2009 $88
RadNet Quarterly Receivables
(Millions of US $)
2024-12-31 $186
2024-09-30 $199
2024-06-30 $195
2024-03-31 $190
2023-12-31 $164
2023-09-30 $168
2023-06-30 $174
2023-03-31 $176
2022-12-31 $166
2022-09-30 $173
2022-06-30 $166
2022-03-31 $160
2021-12-31 $135
2021-09-30 $152
2021-06-30 $157
2021-03-31 $147
2020-12-31 $130
2020-09-30 $137
2020-06-30 $126
2020-03-31 $144
2019-12-31 $155
2019-09-30 $151
2019-06-30 $159
2019-03-31 $157
2018-12-31 $149
2018-09-30 $156
2018-06-30 $152
2018-03-31 $162
2017-12-31 $156
2017-09-30 $169
2017-06-30 $170
2017-03-31 $170
2016-12-31 $164
2016-09-30 $183
2016-06-30 $165
2016-03-31 $178
2015-12-31 $163
2015-09-30 $159
2015-06-30 $156
2015-03-31 $153
2014-12-31 $148
2014-09-30 $155
2014-06-30 $147
2014-03-31 $141
2013-12-31 $134
2013-09-30 $134
2013-06-30 $139
2013-03-31 $135
2012-12-31 $129
2012-09-30 $129
2012-06-30 $131
2012-03-31 $134
2011-12-31 $128
2011-09-30 $122
2011-06-30 $117
2011-03-31 $105
2010-12-31 $96
2010-09-30 $95
2010-06-30 $94
2010-03-31 $88
2009-12-31 $88
2009-09-30 $92
2009-06-30 $95
2009-03-31 $97
Sector Industry Market Cap Revenue
Medical Medical - Outpatient & Home Care $4.453B $1.617B
RadNet, Inc., is a national market leader providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers. RadNet offers to its patients and referring physicians the full spectrum of diagnostic imaging exams, including PET/CT, MRI, CT, Nuclear Medicine, Mammography, Ultrasound and X-ray, as well as numerous other procedures. RadNet utilizes best of breed technology to appropriately serve the medical communities in which it operates.
Stock Name Country Market Cap PE Ratio
Fresenius SE (FSNUY) Germany $21.804B 0.00
Quest Diagnostics (DGX) United States $19.317B 19.51
DaVita (DVA) United States $11.363B 14.49
Encompass Health (EHC) United States $9.962B 22.32
Chemed (CHE) United States $8.236B 25.31
Elanco Animal Health (ELAN) United States $5.492B 13.07
Option Care Health (OPCH) United States $5.459B 25.87
Amedisys (AMED) United States $2.998B 21.34
LifeStance Health (LFST) United States $2.904B 0.00
Addus HomeCare (ADUS) United States $1.974B 22.91
Astrana Health (ASTH) United States $1.946B 26.61
U.S Physical Therapy (USPH) United States $1.298B 34.13
Pennant (PNTG) United States $0.864B 34.93
Aveanna Healthcare Holdings (AVAH) United States $0.799B 0.00
Atai Life Sciences (ATAI) Germany $0.305B 0.00
Bioqual (BIOQ) United States $0.054B 0.00
Daxor (DXR) United States $0.036B 0.00
Ontrak (OTRK) United States $0.007B 0.00
MEDIROM Healthcare Technologies (MRM) Japan $0.004B 0.00
IMAC Holdings (BACK) United States $0.001B 0.00
Psychemedics (PMD) United States $0.000B 0.00